{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T09:57:01Z","timestamp":1783850221018,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcyt.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:15:45Z","timestamp":1754428545000},"page":"1344-1350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Very early recovery of T cells after alpha\/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-1384","authenticated-orcid":false,"given":"Svetlana","family":"Glushkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Shelikhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-9657","authenticated-orcid":false,"given":"Kirill","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dunaikina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Blagov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Pershin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Vedmedskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fadeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Arakelyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-8299","authenticated-orcid":false,"given":"Yakov","family":"Muzalevskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Kazachenok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Skvortsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Balashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0093","authenticated-orcid":false,"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jcyt.2025.07.005_bib0001","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jcyt.2025.07.005_bib0002","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0003","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","article-title":"Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia","volume":"101","author":"Lang","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2025.07.005_bib0004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0b013e3283582340","article-title":"Negative depletion of CD3+ and TcR\u03b1\u03b2+ T cells","volume":"19","author":"Handgretinger","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","article-title":"Depletion of T-cell receptor alpha\/beta and CD19 positive cells from apheresis products with the CliniMACS device","volume":"15","author":"Schumm","year":"2013","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.005_bib0006","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.07.005_bib0007","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol [Internet]"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","article-title":"Immune reconstitution after haploidentical hematopoietic stem cell transplantation","volume":"20","author":"Chang","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.005_bib0009","first-page":"413","article-title":"T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life","volume":"16","author":"Storek","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/leu.2016.321","article-title":"Tracking T-cell immune reconstitution after TCR\u03b1\u03b2\/CD19-depleted hematopoietic cells transplantation in children","volume":"31","author":"Zvyagin","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0011","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41409-020-01128-2","article-title":"T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after \u03b1\u03b2 T cell-depleted hematopoietic stem cell transplantation","volume":"56","author":"Blagov","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.005_bib0012","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/1744666X.2016.1123091","article-title":"Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Lucarelli","year":"2016","journal-title":"Exp Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0013","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.jtct.2021.01.010","article-title":"Serotherapy-Free regimen improves non-relapse mortality and immune recovery among the recipients of \u03b1\u03b2 TCell\u2013Depleted haploidentical grafts: retrospective study in childhood leukemia","volume":"27","author":"Shelikhova","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2025.07.005_bib0014","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41409-021-01232-x","article-title":"Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of \u03b1\u03b2 T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia","volume":"56","author":"Dunaikina","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.005_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41409-017-0035-y","article-title":"Low-dose donor memory T-cell infusion after TCR alpha\/beta depleted unrelated and haploidentical transplantation: results of a pilot trial","volume":"53","author":"Maschan","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.005_bib0016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41409-019-0531-3","article-title":"Outcome of \u03b1\u03b2 T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission","volume":"55","author":"Maschan","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0017","doi-asserted-by":"crossref","first-page":"435.e1","DOI":"10.1016\/j.jtct.2024.01.070","article-title":"Impact of natural killer cell-associated factors on acute leukemia outcomes after haploidentical hematopoietic stem cell transplantation with \u03b1\u03b2 T cell depletion in a pediatric cohort","volume":"30","author":"Glushkova","year":"2024","journal-title":"Transplantat Cell Ther"},{"key":"10.1016\/j.jcyt.2025.07.005_bib0018","article-title":"One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study","author":"Popov","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0019","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17650\/1818-8346-2016-11-4-64-73","article-title":"Standardization of flow cytometric minimal residual disease monitoring in children with b-cell precursor acute lymphoblastic leukemia. Russia\u2013Belarus multicenter group experience","volume":"11","author":"Popov","year":"2016","journal-title":"Onkogematologi\u00e2."},{"issue":"S1","key":"10.1016\/j.jcyt.2025.07.005_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"On behalf of the EBMT Statistical Committee. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48","author":"Iacobelli","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.07.005_bib0021","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3389\/fimmu.2019.02504","volume":"10","author":"Diaz","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.005_bib0022","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/bloodadvances.2020002444","article-title":"\u03b1\u03b2 T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies","volume":"5","author":"De Witte","year":"2021","journal-title":"Blood Advances"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.005_bib0023","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.jcyt.2025.07.005_bib0024","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2009.05.015","article-title":"Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies","volume":"15","author":"Le Blanc","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.005_bib0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/bmt.2014.284","article-title":"Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort","volume":"50","author":"Gul","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.005_bib0026","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2007.07.005","article-title":"Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation","volume":"13","author":"Savani","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2025.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/10428194.2016.1265113","article-title":"Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant","volume":"58","author":"Goldberg","year":"2017","journal-title":"Leukemia Lymphoma"},{"issue":"12","key":"10.1016\/j.jcyt.2025.07.005_bib0028","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bmt.1705381","article-title":"Rapid helper T-cell recovery above 200 \u00d7 106\/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2025.07.005_bib0029","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcyt.2020.05.005","article-title":"Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"Van Roessel","year":"2020","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jcyt.2025.07.005_bib0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcyt.2023.05.012","article-title":"Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis","volume":"25","author":"Troullioud Lucas","year":"2023","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2025.07.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156777","article-title":"Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.005_bib0032","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematology"},{"issue":"11","key":"10.1016\/j.jcyt.2025.07.005_bib0033","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1200\/JCO.2017.77.1774","article-title":"Fine-Tuning antithymocyte globulin dosing and harmonizing clinical trial design","volume":"36","author":"Boelens","year":"2018","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.jcyt.2025.07.005_bib0034","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2015.08.028","article-title":"Immune reconstitution after allogeneic hematopoietic cell transplantation in children","volume":"22","author":"De Koning","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2025.07.005_bib0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/14653249.2011.575356","article-title":"Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation","volume":"13","author":"Hanley","year":"2011","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.005_bib0036","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I\u2013II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.jcyt.2025.07.005_bib0037","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925007856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925007856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:07:54Z","timestamp":1761235674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925007856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1465324925007856"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.07.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very early recovery of T cells after alpha\/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}